Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for prevention of chronic pain after acute whiplash injury
ACTRN12617000059369Phase 4Recruiting
- Sponsor
- The University of Queensland
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Whiplash Associated Disorder (WAD) comparing Pregabalin + advice booklet with Placebo + advice booklet (2 arms). Primary endpoint: Neck pain intensity at 3 months. Started Mar 2017; status: recruiting.
02
Drugs
pregabalin
03
Conditions
Whiplash Associated Disorder (WAD)
Beyond the preview
Go deeper on ACTRN12617000059369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000059369.